REVIEW article
Front. Oncol.
Sec. Neuro-Oncology and Neurosurgical Oncology
Methylation Profiling in Neuropathological Tumors Diagnosis: A Comprehensive Review
Provisionally accepted
- 1Vanderbilt University Medical Center, Nashville, United States
- 2Jordan Hospital, Amman, Jordan
- 3Jordan University of Science and Technology, Irbid, Jordan
- 4King Hussein Cancer Center, Amman, Jordan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
DNA methylation profiling has emerged as a transformative tool in the diagnosis and classification of central nervous system (CNS) tumors. Traditional approaches like histology, immunohistochemistry, and targeted molecular testing cannot fully capture the biological and clinical diversity of these neoplasms. In contrast, genome-wide methylation analysis provides highly reproducible epigenetic "fingerprints" that reflect both lineage and oncogenic alterations, enabling objective tumor classification, refinement of existing categories, and discovery of novel entities. This comprehensive review summarizes the principles of DNA methylation, available platforms, and the application of methylation-based classifiers across major CNS tumor groups, including diffuse gliomas, medulloblastomas, ependymomas, and meningiomas. We highlight how methylation profiling complements other molecular techniques by simultaneously generating copy number profiles and promoter methylation data, consolidating multiple diagnostic assays into a single platform. Practical considerations such as tissue quality, bioinformatic pipelines, interpretation thresholds, and cost are addressed, as are comparisons with sequencing, RNA expression, and immunohistochemistry. Finally, we explore future directions, including nanopore-based rapid testing, liquid biopsy, and artificial intelligence, which promise to extend the reach and clinical utility of methylation profiling. Collectively, these advances are establishing DNA methylation analysis as a cornerstone of precision neuropathology, aligning diagnostic and prognostic assessment with tumor biology to improve patient care.
Keywords: Central Nervous System Neoplasms, DNA methylation profiling, Ependymoma, Epigenomics, Glioma, Medulloblastoma, Meningioma, Neuropathology
Received: 08 Oct 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Al Sharie, Sawaftah, Qasim and Al-Hussaini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Maysa Al-Hussaini
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.